Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

fibrosis/protease

De link wordt op het klembord opgeslagen
Bladzijde 1 van 25 resultaten
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a composition and method for treating pancreatic enzyme insufficiency, particularly lipid malabsorbtion associated with cystic fibrosis. 2. Description of Related Art Various diseased states such as pancreatitis,

Peptoid and nonpeptoid containing .alpha.-keto oxadiazoles as serine protease inhibitors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes, which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in common a catalytic triad consisting of Serine-195, Histidine-57 and Aspartic acid-102(chymotrypsin numbering system). Human

Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes, which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in common a catalytic triad consisting of Serine-195, Histidine-57 and Aspartic acid-102(chymotrypsin numbering system). Human

Protease variants for pharmaceutical use

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
REFERENCE TO A SEQUENCE LISTING This application contains a Sequence Listing in computer readable form. The computer readable form is incorporated herein by reference. TECHNICAL FIELD The present invention relates to a protease having at least 90% identity to amino acids 1-188 of SEQ ID NO: 1, and

Serine protease inhibitors-N-substituted derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin.

Serine protease inhibitors-keto and di-keto containing ring systems

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes which include elastase, chymotrypsin, cathepsin G, trypsin and thrombin.

Val-pro containing .alpha.-keto oxadiazoles as serine protease inhibitors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes, which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in common a catalytic triad consisting of Serine-195, Histidine-57 and Aspartic acid-102 (chymotrypsin numbering system). Human

Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole nonpeptides, which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes, which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in

Serine protease inhibitors-proline analogs

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin.

Serine protease inhibitors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole nonpeptides, which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes, which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in

Serine protease inhibitor--tripeptoid analogs

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases. BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin.

Serine protease inhibitors-cycloheptane derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION The serine proteases are a class of enzymes which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin. These proteases have in common a catalytic triad consisting of Serine-195, Histidine-57 and Aspartic acid-102 (chymotrypsin numbering system). Human

Combined biomarker measurement of fibrosis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION Technical Field of the Invention The present invention relates in a first aspect to a monoclonal antibody which is specifically reactive with the C-terminal neo-epitope of PIIINP, and its use in a method of immunoassay for detecting and quantifying PIIINP. In a further

Modulators of protease activated receptors

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
CROSS-REFERENCE TO RELATED APPLICATIONS The present application is the United States National Phase of PCT Application No. PCT/AU2012/000891, filed Jul. 27, 2012, which claims priority to PCT/AU2011/000959, filed Jul. 28, 2011, and to AU 2011904617, filed Nov. 7, 2011, the entire contents of each of

Lipase variants for pharmaceutical use

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
REFERENCE TO A SEQUENCE LISTING This application contains a Sequence Listing in computer readable form. The computer readable form is incorporated herein by reference. TECHNICAL FIELD The present invention relates to a lipase for use as a medicament, which lipase (a) has at least 50% identity to the
Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge